{
    "nct_id": "NCT03841435",
    "official_title": "Feasibility Study of Hypofractionated Radiotherapy in the Setting of Recurrent Diffuse Intrinsic Pontine Glioma",
    "inclusion_criteria": "1. Patients must be ≤30 years of age\n2. Patients must have a diagnosis of progressive DIPG.\n3. Received prior IMRT based definitive radiotherapy to a dose of ≥54 Gy.\n4. The patient and or parent/legal guardian must be physically and mentally capable of signing the consent form of their own volition.\n5. Steroids dosage must be unchanged for 5 days.\n6. No Bevacizumab within 21 days (Half-life 11 days ~)\nHealthy volunteers allowed\nMust have maximum age of 30 Years",
    "exclusion_criteria": "1. Patients with incomplete medical records\n2. Patients with prior history of reirradiation for DIPG\n3. Life expectancy < or equal to 1 month\n4. Pregnant women\n5. Age >30\n6. Prisoners\n7. Concurrent systemic therapy at the time of reirradiation\n8. Physically or mentally incapable of signing the consent form of their own volition\n9. < 6 mos time interval between completion of initial RT to start of reRT.",
    "miscellaneous_criteria": ""
}